Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01720030
PHASE2/PHASE3
Levosimendan in Acute Kidney Injury Study
Sponsor: VieCuri Medical Centre
View on ClinicalTrials.gov
Summary
We hypothesise that levosimendan will have a positive influence on renal function during acute kidney injury in adult intensive care patients.
Official title: Prospective, Randomized, Monocenter, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Levosimendan in Intensive Care Patients With Acute Kidney Injury
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2016-09
Completion Date
2017-10
Last Updated
2026-08-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
Levosimendan
Verum therapy
DRUG
Conventional therapy
Placebo therapy to safeguard blinding
Locations (1)
VieCuri Medical Center
Venlo, Limburg, Netherlands